Longitudinal Study of Gray Matter Changes in Parkinson Disease

REFERENCES

1. 1.↵
   2. Burton EJ,
   3. McKeith IG,
   4. Burn DJ, et al

   . Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004;127:791–800 doi:10.1093/brain/awh088 pmid:14749292

   Abstract/FREE Full Text
2. 2.↵
   2. Beyer MK,
   3. Larsen JP,
   4. Aarsland D

   . Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 2007;69:747–54 doi:10.1212/01.wnl.0000269666.62598.1c pmid:17709706

   Abstract/FREE Full Text
3. 3.↵
   2. Kostic VS,
   3. Agosta F,
   4. Petrović I, et al

   . Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 2010;75:857–63 doi:10.1212/WNL.0b013e3181f11c1d pmid:20686125

   Abstract/FREE Full Text
4. 4.↵
   2. Kostic VS,
   3. Agosta F,
   4. Pievani M, et al

   . Pattern of brain tissue loss associated with freezing of gait in Parkinson disease. Neurology 2012;78:409–16 doi:10.1212/WNL.0b013e318245d23c pmid:22282641

   Abstract/FREE Full Text
5. 5.↵
   2. Compta Y,
   3. Ibarretxe-Bilbao N,
   4. Pereira J, et al

   . Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia. Parkinsonism Relat Disord 2012;18:941–47 doi:10.1016/j.parkreldis.2012.04.028 pmid:22595621

   CrossRefPubMed
6. 6.↵
   2. Hong J,
   3. Lee JE,
   4. Sohn YH, et al

   . Neurocognitive and atrophic patterns in Parkinson's disease based on subjective memory complaints. J Neurol 2012;259:1706–12 doi:10.1007/s00415-011-6404-3 pmid:22289965

   CrossRefPubMed
7. 7.↵
   2. Lee EY,
   3. Sen S,
   4. Eslinger PJ, et al

   . Early cortical gray matter loss and cognitive correlates in non-demented Parkinson's patients. Parkinsonism Relat Disord 2013;19:1088–93 doi:10.1016/j.parkreldis.2013.07.018 pmid:23932064

   CrossRefPubMed
8. 8.↵
   2. Lee JE,
   3. Cho KH,
   4. Ham JH, et al

   . Olfactory performance acts as a cognitive reserve in non-demented patients with Parkinson's disease. Parkinsonism Relat Disord 2014;20:186–91 doi:10.1016/j.parkreldis.2013.10.024 pmid:24262869

   CrossRefPubMed
9. 9.↵
   2. Kassubek J,
   3. Juengling FD,
   4. Hellwig B, et al

   . Thalamic gray matter changes in unilateral Parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neurosci Lett 2002;323:29–32 doi:10.1016/S0304-3940(02)00111-8 pmid:11911983

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Pagonabarraga J,
    3. Soriano-Mas C,
    4. Llebaria G, et al

    . Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease. Parkinsonism Relat Disord 2014;20:290–96 doi:10.1016/j.parkreldis.2013.11.017 pmid:24373690

    CrossRefPubMed
11. 11.↵
    2. Nagano-Saito A,
    3. Washimi Y,
    4. Arahata Y, et al

    . Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 2005;64:224–29 doi:10.1212/01.WNL.0000149510.41793.50 pmid:15668417

    Abstract/FREE Full Text
12. 12.↵
    2. Ibarretxe-Bilbao N,
    3. Ramirez-Ruiz B,
    4. Tolosa E, et al

    . Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia. J Neurol 2008;255:1324–31 doi:10.1007/s00415-008-0885-8 pmid:18821043

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Tessitore A,
    3. Amboni M,
    4. Cirillo G, et al

    . Regional gray matter atrophy in patients with Parkinson disease and freezing of gait. AJNR Am J Neuroradiol 2012;33:1804–09 doi:10.3174/ajnr.A3066 pmid:22538070

    Abstract/FREE Full Text
14. 14.↵
    2. Ellfolk U,
    3. Joutsa J,
    4. Rinne JO, et al

    . Striatal volume is related to phonemic verbal fluency but not to semantic or alternating verbal fluency in early Parkinson's disease. J Neural Transm 2014;121:33–40 doi:10.1007/s00702-014-1217-z pmid:23913130

    CrossRefPubMed
15. 15.↵
    2. Ramirez-Ruiz B,
    3. Marti MJ,
    4. Tolosa E, et al

    . Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol 2005;252:1345–52 doi:10.1007/s00415-005-0864-2 pmid:15995795

    CrossRefPubMedWeb of Science
16. 16.↵
    Parkinson Progression Marker Initiative. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol 2011;95:629–35 doi:10.1016/j.pneurobio.2011.09.005 pmid:21930184

    CrossRefPubMed
17. 17.↵
    2. Yesavage JA

    . Geriatric Depression Scale. Psychopharmacol Bull 1988;24:709–11 pmid:3249773

    PubMedWeb of Science
18. 18.↵
    2. Ashburner J

    . A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95–113 doi:10.1016/j.neuroimage.2007.07.007 pmid:17761438

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Good CD,
    3. Johnsrude IS,
    4. Ashburner J, et al

    . A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001;14:21–36 doi:10.1006/nimg.2001.0786 pmid:11525331

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Pan P,
    3. Shi H,
    4. Zhong J, et al

    . Gray matter atrophy in Parkinson's disease with dementia: evidence from meta-analysis of voxel-based morphometry studies. Neurol Sci 2013;34:613–19 doi:10.1007/s10072-012-1250-3 pmid:23184330

    CrossRefPubMed
21. 21.↵
    2. Binkofski F,
    3. Reetz ,
    4. Gaser C, et al

    . Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia. Neurology 2007;69:842–50 doi:10.1212/01.wnl.0000267844.72421.6c pmid:17724286

    Abstract/FREE Full Text
22. 22.↵
    2. Krabbe K,
    3. Karlsborg M,
    4. Hansen A, et al

    . Increased intracranial volume in Parkinson's disease. J Neurol Sci 2005;239:45–52 doi:10.1016/j.jns.2005.07.013 pmid:16225890

    CrossRefPubMed
23. 23.↵
    2. Helmich RC,
    3. de Lange FP,
    4. Bloem BR, et al

    . Cerebral compensation during motor imagery in Parkinson's disease. Neuropsychologia 2007;45:2201–15 doi:10.1016/j.neuropsychologia.2007.02.024 pmid:17448507

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Palop JJ,
    3. Chin J,
    4. Mucke L

    . A network dysfunction perspective on neurodegenerative diseases. Nature 2006;443:768–73 doi:10.1038/nature05289 pmid:17051202

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Jernigan TL,
    3. Archibald SL,
    4. Berhow MT, et al

    . Cerebral structure on MRI, Part I: localization of age-related changes. Biol Psychiatry 1991;29:55–67 doi:10.1016/0006-3223(91)90993-V pmid:2001446

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Walhovd KB,
    3. Fjell AM,
    4. Reinvang I, et al

    . Effects of age on volumes of cortex, white matter and subcortical structures. Neurobiol Aging 2005;26:1261–70; discussion 1275–78 doi:10.1016/j.neurobiolaging.2005.05.020 pmid:16005549

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Abedelahi A,
    3. Hasanzadeh H,
    4. Hadizadeh H, et al

    . Morphometric and volumetric study of caudate and putamen nuclei in normal individuals by MRI: effect of normal aging, gender and hemispheric differences. Pol J Radiol 2013;78:7–14 doi:10.12659/PJR.889364 pmid:24115954

    CrossRefPubMed
28. 28.↵
    2. Raz N,
    3. Schmiedek F,
    4. Rodrigue KM, et al

    . Differential brain shrinkage over 6 months shows limited association with cognitive practice. Brain Cogn 2013;82:171–80 doi:10.1016/j.bandc.2013.04.002 pmid:23665948

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Raz N,
    3. Lindenberger U,
    4. Rodrigue KM, et al

    . Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cerebral Cortex 2005;15:1676–89 doi:10.1093/cercor/bhi044 pmid:15703252

    Abstract/FREE Full Text
30. 30.↵
    2. Alexander GE,
    3. DeLong MR,
    4. Strick PL

    . Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 1986;9:357–81 doi:10.1146/annurev.ne.09.030186.002041 pmid:3085570

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Poston KL,
    3. Eidelberg D

    . Functional brain networks and abnormal connectivity in the movement disorders. Neuroimage 2012;62:2261–70 doi:10.1016/j.neuroimage.2011.12.021 pmid:22206967

    CrossRefPubMed
32. 32.↵
    2. Jokinen P,
    3. Brück A,
    4. Aalto S, et al

    . Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord 2009;15:88–93 doi:10.1016/j.parkreldis.2008.03.005 pmid:18434233

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Rinne JO,
    3. Portin R,
    4. Ruottinen H, et al

    . Cognitve impairment and the brain dopaminergic system in Parkinson disease: [F18] fluorodopa positron emission tomographic study. Arch Neurol 2000;57:470–75 doi:10.1001/archneur.57.4.470 pmid:10768619

    CrossRefPubMedWeb of Science
34. 34.↵
    2. Albin RL,
    3. Young AB,
    4. Penney JB

    . The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366–75 doi:10.1016/0166-2236(89)90074-X pmid:2479133

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Evarts EV,
    3. Kimura M,
    4. Wurtz RH, et al

    . Behavioral correlates of activity in basal ganglia neurons. Trends in Neurosci 1984;7:447–53 doi:10.1016/S0166-2236(84)80151-4

    CrossRefWeb of Science
36. 36.↵
    2. DeLong MR,
    3. Wichmann T

    . Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007;64:20–24 doi:10.1001/archneur.64.1.20 pmid:17210805

    CrossRefPubMedWeb of Science
37. 37.↵
    2. Halliday GM

    . Thalamic changes in Parkinson's disease. Parkinsonism Relat Disord 2009;15:S152–S155 doi:10.1016/S1353-8020(09)70804-1

    CrossRefPubMed
38. 38.↵
    2. Fjell AM,
    3. Westlye LT,
    4. Grydeland H, et al

    ; Alzheimer Disease Neuroimaging Initiative. Critical ages in the life course of the adult brain: nonlinear subcortical aging. Neurobiol Aging 2013;34:2239–47 doi:10.1016/j.neurobiolaging.2013.04.006 pmid:23643484

    CrossRefPubMedWeb of Science